The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 23, 2009
Filed:
Aug. 15, 2003
Richard Albang, Martinsried, DE;
Andreas Fritz, Martinsried, DE;
Oliver Heinrich, Martinsried, DE;
Hilmar Ilgenfritz, Martinsried, DE;
Dieter Maier, Martinsried, DE;
Christian Wagner, Martinsried, DE;
Ulrike Folkers, München, DE;
Beatrix Gerhard, Unterhaching, DE;
Fabio Spreafico, Martinsried, DE;
Lex DE Boer, Wateringen, NL;
Roelf Bernhard Meima, AH Kamerik, NL;
Richard Albang, Martinsried, DE;
Andreas Fritz, Martinsried, DE;
Oliver Heinrich, Martinsried, DE;
Hilmar Ilgenfritz, Martinsried, DE;
Dieter Maier, Martinsried, DE;
Christian Wagner, Martinsried, DE;
Ulrike Folkers, München, DE;
Beatrix Gerhard, Unterhaching, DE;
Fabio Spreafico, Martinsried, DE;
Lex De Boer, Wateringen, NL;
Roelf Bernhard Meima, AH Kamerik, NL;
DSM IP Assets B.V., Heerlen, NL;
Abstract
The invention relates to a newly identified polynucleotide sequence comprising a gene that encodes a novel lipolytic enzyme from. The invention features the full length nucleotide sequence of the novel gene, the cDNA sequence comprising the full length coding sequence of the novel lipolytic enzyme as well as the amino acid sequence of the full-length functional protein and functional equivalents thereof. The invention also relates to methods of using these enzymes in industrial processes and methods of diagnosing fungal infections. Also included in the invention are cells transformed with a polynucleotide according to the invention and cells wherein a lipolytic enzyme according to the invention is genetically modified to enhance its activity and/or level of expression.